Good old fireside chat, page-91

I think AGY is overvalued as well but then investors now invest on solid fundamentals, low risk and forward earning projections and don't mind if they don't get rewards for a couple of years. As long as the fundamentals are sound and there's been a lot of derisking they get on the stock. The 2 risks I see for AGY are they don't have a JORC yet and haven't actually produced lithium in the lab. These arent major risks and once addressed they should be worth at least over $500M in my opinion, considering strong forward lithium sale projections.

ASN also has very solid fundamentals but the main risk is proving the lithium extraction method on a large commercial stage. To me thats a bigger risk than AGY's evaporation method which has been commercially proven on a general scale. But ASN is still way undervalued for its potential. Both companies stand to generate high profit margins considering they are producing lithium carbonate as opposed to most hard rock plays selling spodumeme concentrate.